Financials
- Market Capitalization 3.07 B
- Employee 339
- Founded 2016
- CEO N/A
- Website www.veratx.com
- Headquarter Delaware, United States
- FIGI BBG00Q72WYG3
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-7.26
Relación precio/flujo de caja
-2 982.67
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1687 | ELVN Enliven Therapeutics, Inc. - Common Stock | 51.44 USD | +1.12% | +1.22% | +12.73% | +148.98% | 3.13 B USD | ||
| 1701 | CLDX Celldex Therapeutics, Inc. - Common Stock | 38.68 USD | +0.39% | -0.31% | +21.94% | +42.00% | 3.04 B USD | ||
| 1739 | IRON Disc Medicine, Inc. - Common Stock | 75.98 USD | 0.00% | -2.71% | +10.02% | +31.02% | 2.90 B USD | ||
| 1826 | QURE uniQure N.V. - Ordinary Shares | 42.76 USD | +4.04% | +5.61% | +54.09% | +192.88% | 2.70 B USD |